The 31st Annual Meeting of the Society for Neuro-Oncology (SNO) in Philadelphia, November 13-15, is bringing together an unusually broad group of biotechnology companies pursuing new approaches to some of the most difficult-to-treat brain cancers. Among the participants are NeOnc Technologies Holdings (NASDAQ: NTHI), Nuvation Bio (NYSE: NUVB), Jazz Pharmaceuticals (NASDAQ: JAZZ), Cerenome (NASDAQ: CNSY), BioLineRx (NASDAQ: BLRX), Alpha Tau Medical (NASDAQ: DRTS), and privately held Diakonos Oncology. Their programs range from targeted drugs and immunotherapy to localized radiation and experimental drug-delivery technologies.The 31st Annual Meeting of the Society for Neuro-Oncology (SNO) in Philadelphia, November 13-15, is bringing together an unusually broad group of biotechnology companies pursuing new approaches to some of the most difficult-to-treat brain cancers. Among the participants are NeOnc Technologies Holdings (NASDAQ: NTHI), Nuvation Bio (NYSE: NUVB), Jazz Pharmaceuticals (NASDAQ: JAZZ), Cerenome (NASDAQ: CNSY), BioLineRx (NASDAQ: BLRX), Alpha Tau Medical (NASDAQ: DRTS), and privately held Diakonos Oncology. Their programs range from targeted drugs and immunotherapy to localized radiation and experimental drug-delivery technologies.

Vancouver, British Columbia, November 13th, 2026, FinanceWire

Austin, Texas, November 13th, 2026, FinanceWire

SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, announced the promotion of Dr. Vishwa Srivastava to president and the appointment of Gary Lo as chief financial officer. Srivastava, who previously served as CEO of the company’s Asia Pacific operations, will focus on building its U.S. business and leading global operations. Both executives […]